Ignite Creation Date:
2025-12-25 @ 4:07 AM
Ignite Modification Date:
2026-01-16 @ 7:49 AM
Study NCT ID:
NCT03258320
Status:
RECRUITING
Last Update Posted:
2024-04-17
First Post:
2017-08-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Randomised Trial of Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin (CDMS) Plus Surgery for Prostate Cancer Patients Without Metastasis
Sponsor:
Shanghai Jiao Tong University School of Medicine
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
PCA-81472709
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None